Author

M-YC Polley

Observed name: M. Polley

Institutions: Royal Marsden NHS Foundation Trust, Mayo Clinic, University of Nottingham, Eli Lilly (United States), University of California, Irvine, Karolinska Institutet, German Breast Group, GEICAM – Spanish Breast Cancer Group, SWOG Cancer Research Network

Observed institutions: Royal Marsden NHS Foundation Trust, Mayo Clinic, University of Nottingham, Eli Lilly (United States), University of California, Irvine, Karolinska Institutet, German Breast Group, GEICAM – Spanish Breast Cancer Group, SWOG Cancer Research Network

OpenAlex ID: A5090835883

Abstract P2-07-05: A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced stage breast cancer treated with first-line endocrine therapy

2019 · M-YC Polley, MN Dickler, et al. · Cancer Research

Abstract P1-06-07: Mayo clinic TNBC outcome calculator: A clinical calculator to predict disease relapse and survival in women with triple-negative breast cancer

2018 · M-YC Polley, RA Leon-Ferre, et al. · Cancer Research

The benefit of individualised programmes of complementary therapies for breast Cancer patients at Breast Cancer Haven

2006 · M. Polley, C. Hoffman, et al. · European Journal of Cancer Supplements

Works count: 3

Citation count:

H-index:

I10-index: